This pharma stock has doubled investors’ money in one year, know about it

Multibagger Stock: Shares of Gland Pharma, listed in November 2020, have risen to Rs 3,830 per share from its IPO issue price of Rs 1,500 per share currently, doubling investors’ money during the period. In a recent note, Axis Securities has recommended Krishna Institute of Medical Sciences (KIMS) as well as Gland Pharma and it is among their top picks.

The note said, “While manufacturing of COVID-19 products such as Sputnik-V, Remdesivir acts as a strong growth for Gland Pharma, the US could drive topline changes in product mix, leading to QoQ (QoQ). ) Margins may improve. The brokerage expects the pharma company to post stable net profit in Q2 on account of lower taxes. However, this quarter will see a marginal decline in overall sales on a QoQ basis and there will be a loss of revenue from the product driven by Kovid.

For Krishna Institute of Medical Sciences (KIMS), on Q2 Axis Securities said that lower Covid-patient volumes may bring in lower revenues, however, a change in product mix may improve margins on a sequential basis. The shares of KIMS made their debut in the stock market in June this year. The shares of KIMS are currently trading at around Rs 1,155 per share, up from its IPO issue price of Rs 825 per share.

Brokerage firm Axis Securities said in a note on Monday that the India Pharma Market (IPM) grew 16%, driven by a jump and recovery in sales of non-Covid-19 products. It expects the pharma universe to report high single-digit growth (8% YoY), primarily driven by the injectables and generics segment.

Brokerage firm Axis Securities said in a note on Monday that the India Pharma Market (IPM) grew 16%, driven by a jump and recovery in sales of non-Covid-19 products. The brokerage firm expects Pharma Universe to achieve high singer digit growth (8% YoY), driven primarily by the injectables and generics segment.

Disclaimer: (The information provided here is for informational purposes only. It is important to mention here that investing in the market is subject to market risks. Always consult an expert before investing money as an investor. Anyone from ABPLive.com Also investing money is never advised here.)

Read also:

Multibagger Stock Tips: This multibagger stock gave 151% return in 2021, brokerage firm claims – will continue to rise

Cryptocurrency Prices Today: Bounce in Global Cryptocurrency Market, slight gain of 0.15% in Bitcoin